Effects of high-flux hemodialysis on plasma adrenomedullin and sustained hypotension in elderly hemodialysis patients  

作　　者：ZHANG Dong SUN Xue-feng MA Zhi-fang ZHU Han-yu WANG Yuan-da CHEN Xiang-mei 

机构地区：[1]Institute of Nephrology, Chinese People's Liberation Army General Hospital, Beijing 100853, China

出　　处：《Chinese Medical Journal》2011年第6期907-910,共4页中华医学杂志（英文版）

基　　金：This work was supported by the grants from the National Basic Research Program （973 Program） of China （No. 2007CB507400）, the National Natural Science Foundation of China （No. 30871171）, and the Military ＂Eleven-five＂ Special Fund of Medical Science （No. 08Z034）.

摘　　要：Background Sustained hypotension during hemodialysis （HD） is an important clinical issue. Plasma adrenomedullin （AM） is increased in HD patients with sustained hypotension, but little is known about whether removing AM can improve hypotension. The objective of this study was to investigate the beneficial effects of hemodialysis using a high-flux dialyzer on removal of increased plasma AM levels and improving low blood pressure in elderly HD patients with sustained hypotension.Methods Forty-eight elderly patients （age 65 or older） who had undergone maintenance HD for more than one year were recruited and studied. We evaluated plasma levels of AM in sustained hypotension （SH; n=28） and normotensive （NT; n=20） patients. The patients with hypotension were further divided into two subgroups and treated with eitherhigh-flux dialyzer or low-flux dialyzer for 3 months. Plasma adrenomedullin levels and blood pressure were analyzed at days 0 and 181.Results Plasma levels of AM were significantly higher in SH than in NT patients （（24.92±3.7） ng/L vs. （15.52±6.01） ng/L,P〈0.05）, and were inversely correlated with mean arterial blood pressure （MAP） at pre-HD. After 3 months, the level of plasma AM in high-flux group was decreased （（24.58±4.36） ng/L vs. （16.18±5.08） ng/L, P 〈0.05）, but MAP was increased （（67.37±4.31） mmHg vs. （74.79±3.59） mmHg, P〈0.05）. There was no obvious change in low-flux group.Conclusions Plasma AM levels were significantly elevated in elderly HD patients with SH. High-flux dialyzer therapy can decrease plasma AM level and improve hypotension.Background Sustained hypotension during hemodialysis （HD） is an important clinical issue. Plasma adrenomedullin （AM） is increased in HD patients with sustained hypotension, but little is known about whether removing AM can improve hypotension. The objective of this study was to investigate the beneficial effects of hemodialysis using a high-flux dialyzer on removal of increased plasma AM levels and improving low blood pressure in elderly HD patients with sustained hypotension.Methods Forty-eight elderly patients （age 65 or older） who had undergone maintenance HD for more than one year were recruited and studied. We evaluated plasma levels of AM in sustained hypotension （SH; n=28） and normotensive （NT; n=20） patients. The patients with hypotension were further divided into two subgroups and treated with eitherhigh-flux dialyzer or low-flux dialyzer for 3 months. Plasma adrenomedullin levels and blood pressure were analyzed at days 0 and 181.Results Plasma levels of AM were significantly higher in SH than in NT patients （（24.92±3.7） ng/L vs. （15.52±6.01） ng/L,P〈0.05）, and were inversely correlated with mean arterial blood pressure （MAP） at pre-HD. After 3 months, the level of plasma AM in high-flux group was decreased （（24.58±4.36） ng/L vs. （16.18±5.08） ng/L, P 〈0.05）, but MAP was increased （（67.37±4.31） mmHg vs. （74.79±3.59） mmHg, P〈0.05）. There was no obvious change in low-flux group.Conclusions Plasma AM levels were significantly elevated in elderly HD patients with SH. High-flux dialyzer therapy can decrease plasma AM level and improve hypotension.

关 键 词：high-flux dialysis HYPOTENSION ADRENOMEDULLIN 

分 类 号：Q463[生物学—生理学] TH789[机械工程—仪器科学与技术]